Nadmed

3 known investors

NADMED provides an enzymatic, microplate-based assay method and CE-marked/RUO kits that quantify all four forms of NAD and two glutathione species from blood, tissue, or cell samples. It serves research and diagnostic laboratories through kits and laboratory services for redox metabolite analysis and supplement purity testing.

BiotechHealthtechMedical Devices